The global hydroxychloroquine market is estimated to grow at a CAGR of XX% during the forecast period. Significant rise in the incidences of COVID-19 is primarily encouraging the demand for hydroxychloroquine across the countries. As per the World Health Organization (WHO), on 13th April 2020, the number of COVID-19 confirmed cases and mortalities reported globally was 76,498 and 5,702, in particular. Of these, Region of the Americas, which include the US, Canada, Brazil, and Ecuador, and among others had the largest number of incidences globally with 36,804 confirmed cases. This rising incidences of COVID-19 and delay in the launch of COVID-19 vaccine have increased the government focus towards available potential alternatives that could alleviate the effects of COVID-19 among patients.
Browse the full report description Global Hydroxychloroquine Market Size, Share & Trends Analysis Report, By Application (COVID-19, Malaria, Rheumatoid Arthritis, Lupus Erythematosus, and Others), By Dosage Type (100 mg, 200 mg, 400 mg, 600 mg, and 800 mg) and Forecast, 2019-2025 at https://www.omrglobal.com/industry-reports/hydroxychloroquine-market
Therefore, most of the countries have shifted their focus towards hydroxychloroquine owing to its demonstrated antiviral activity in some researches which shows the ability of these class of drugs to alter the activity of immune system with an established safety profile at suitable doses. As per the small clinical trial conducted in France, hydroxychloroquine enables patients to recover from the COVID-19 quickly. However, a study in Beijing witnessed that the drug provided no potential benefit for COVID-19. Several rigorous tests are put in place to test the efficacy of hydroxychloroquine, which includes one sponsored clinical trial by the WHO.
Some of these clinical trials have created an assumption that it may be useful to treat COVID-19 patients. However, it may have certain side-effects as even short-term use could result in dermatological reactions, cardiac arrhythmias, hypoglycemia, and seizures. Even there are weak evidences of hydroxychloroquine for the treatment of COVID-19, several countries have put their efforts to arrange these drugs to combat the effects of COVID-19. For instance, the US, Spain, Germany, and Brazil are some countries using hydroxychloroquine amid COVID-19 outbreak. This, in turn, has increased the demand for these drugs for the treatment of COVID-19 patients.
India is the major producer of hydroxychloroquine tablets and is supplying a considerable amount of drugs to multiple countries. For instance, on 11th April 2020, India declared to ship hydroxychloroquine tablets to 13 countries, such as the US, Brazil, Spain, Bahrain, Germany, Nepal, Bhutan, Bangladesh, Afghanistan, Maldives, Mauritius, Seychelles, and the Dominican Republic. Therefore, the rising incidences of COVID-19 across the globe have been contributing to the growth of the global hydroxychloroquine market.
Global Hydroxychloroquine Market- Segmentation
By Application
By Dosage Type
Global Hydroxychloroquine Market– Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To
learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/hydroxychloroquine-market